Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume $9.37 -0.06 (-0.59%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Astellas Pharma Short Interest DataAstellas Pharma (ALPMY) has a short interest of 25,900 shares. This marks a 2,777.78% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 211,586 shares to cover all short positions.Current Short Interest25,900 sharesPrevious Short Interest900 sharesChange Vs. Previous Month+2,777.78%Dollar Volume Sold Short$256,669.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,809,660,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume104,600 sharesAverage Trading Volume211,586 sharesToday's Volume Vs. Average49% Short Selling Astellas Pharma? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202525,900 shares $256,669.00 +2,777.8%N/A0.1 $9.91 4/15/2025900 shares $8,352.00 -98.5%0.0%0 $9.28 3/31/202560,400 shares $582,709.00 +144.5%0.0%0.4 $9.65 3/15/202524,700 shares $244,283.00 -56.7%0.0%0.1 $9.89 2/28/202557,000 shares $553,470.00 +20.8%0.0%0.3 $9.71 2/15/202547,200 shares $461,144.00 -49.0%0.0%0.1 $9.77 1/31/202592,500 shares $895,400.00 +132.4%N/A0.2 $9.68 1/15/202539,800 shares $385,861.00 +26.4%N/A0.1 $9.70 12/31/202431,500 shares $304,290.00 -58.7%N/A0 $9.66 12/15/202476,200 shares $768,096.00 +150.7%N/A0.1 $10.08 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/202430,400 shares $315,552.00 -69.8%N/A0.1 $10.38 11/15/2024100,500 shares $1.08 million +1,004.4%N/A0.3 $10.70 10/31/20249,100 shares $106,288.00 -79.8%N/A0.1 $11.68 10/15/202445,100 shares $517,297.00 +16.2%N/A0.2 $11.47 9/30/202438,800 shares $444,260.00 +269.5%N/A0.3 $11.45 9/15/202410,500 shares $126,105.00 -75.4%N/A0.1 $12.01 8/31/202442,600 shares $528,666.00 +38.8%N/A0.3 $12.41 8/15/202430,700 shares $351,208.00 -89.7%N/A0.1 $11.44 7/31/2024298,700 shares $3.47 million -11.9%N/A0.6 $11.61 7/15/2024338,900 shares $3.53 million +48.8%N/A1 $10.42 6/30/2024227,800 shares $2.25 million -10.5%N/A0.4 $9.86 6/15/2024254,500 shares $2.42 million +83.5%N/A0.3 $9.51 5/31/2024138,700 shares $1.36 million +87.2%N/A0.2 $9.81 5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55 4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93 2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36 11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65 10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04 9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85 9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91 8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14Feds Just Admitted It—They Can Take Your Cash (Ad)The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.Click here to get the 3 secret strategies you can put in place starting today 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87 6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00 2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68 1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07 10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77 8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30 7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91 5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58 3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66 2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68 2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52 9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23 7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41Feds Just Admitted It—They Can Take Your Cash (Ad)The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.Click here to get the 3 secret strategies you can put in place starting today 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26 4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95 4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08 3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91 12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91 10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91 9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24 8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36 7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70 7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33 6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66 6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47 5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 25,900 shares of ALPMY short. Learn More on Astellas Pharma's current short interest. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 25,900 shares, an increase of 2,777.8% from the previous total of 900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? Here is how the short interest of companies compare to Astellas Pharma: Regeneron Pharmaceuticals, Inc. (2.78%), Daiichi Sankyo Company, Limited (0.01%), Takeda Pharmaceutical Company Limited (0.15%), UCB SA (0.00%), UCB SA (0.13%), Alnylam Pharmaceuticals, Inc. (2.42%), Bayer Aktiengesellschaft (0.00%), Teva Pharmaceutical Industries Limited (2.51%), Royalty Pharma plc (5.42%), Summit Therapeutics Inc. (3.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies REGN Short Interest DSNKY Short Interest TAK Short Interest UCBJY Short Interest UCBJF Short Interest ALNY Short Interest BAYRY Short Interest TEVA Short Interest RPRX Short Interest SMMT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALPMY Stock Free ALPMY Stock Alerts